Boussignac continuous positive airway pressure for the management of acute cardiogenic pulmonary edema: prospective study with a retrospective control group
2007

Boussignac CPAP for Acute Cardiogenic Pulmonary Edema

Sample size: 108 publication Evidence: moderate

Author Information

Author(s): Dieperink Willem, Jaarsma Tiny, van der Horst Iwan CC, Nieuwland Wybe, Vermeulen Karin M, Rosman Hanka, Aarts Leon PHJ, Zijlstra Felix, Nijsten Maarten WN

Primary Institution: University Medical Center Groningen, University of Groningen

Hypothesis

We hypothesized that the major obstacle in treating patients with BCPAP in the CCU would be organizational.

Conclusion

BCPAP was feasible, medically effective, and cost-effective in the treatment of acute cardiogenic pulmonary edema.

Supporting Evidence

  • BCPAP treatment reduced hospital length of stay.
  • Fewer patients required transfers to the intensive care unit for intubation.
  • Estimated savings of approximately € 3,800 per patient were achieved with the BCPAP strategy.

Takeaway

Doctors used a special mask to help patients with breathing problems caused by heart issues, and it worked well and saved money.

Methodology

Patients with acute cardiogenic pulmonary edema were treated with BCPAP in a coronary care unit and compared to a historical control group receiving conventional treatment.

Limitations

The control group data is retrospective and the treatment might have differed slightly due to ongoing advances in treatment.

Participant Demographics

Patients were predominantly male with a mean age of 72 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2261-7-40

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication